Suprachoroidal Injection of Triamcinolone Acetonide With IVT Anti-VEGF in Subjects With Macular Edema Following RVO

A Randomized, Masked, Controlled Trial to Study the Safety and Efficacy of Suprachoroidal
CLS-TA With Intravitreal Anti-VEGF Agent in Subjects With Retinal Vein Occlusion

Inclusion Criteria:

- Has a clinical diagnosis of RVO in the study eye

- Has a CST of ≥ 300 µm in the study eye

- Has an ETDRS BCVA score of ≥ 20 letters read and ≤ 70 letters read in the study eye

- Is naïve to local pharmacologic treatment for RVO in the study eye

Exclusion Criteria:

- Any active ocular disease or infection in the study eye other than RVO

- History of glaucoma, intraocular pressure > 21 mmHg or ocular hypertension requiring
more than one medication

- Any uncontrolled systemic disease that, in the opinion of the Investigator, would
preclude participation in the study

- Any evidence of neovascularization in the study eye